Discover how recaticimab delivers significant LDL-C reduction with extended 12-week dosing, enhancing lipid-lowering therapy ...

Discover how machine learning predicts sepsis-associated ARDS and mortality with high accuracy. Learn about the potential for ...

A new scoring system identifies risk factors for disease recurrence after stem cell transplantation in leukemia patients, ...

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales. Read more.

Discover a study that shows that modulating STAT6 directly may represent an innovative strategy for managing severe, ...

Phase 3 psoriasis trial results highlight the efficacy and safety of icotrokinra, an oral IL-23 therapy showing promise for ...

New research reveals rare aneuploid cells in healthy breast tissues, showing cancer-like mutations that increase with age, ...

A NEW study has demonstrated that menopausal hormone therapy (MHT) impacts brain health in nuanced ways, influenced by age, ...

A NEW study has demonstrated the diagnostic superiority of [68Ga]Ga-NYM046 PET/CT over the conventional [18F]FDG PET/CT in ...

Pfizer's anti-tissue factor pathway inhibitor has been approved for the treatment of haemophilia A & B by the European Commission.

Phase 1 trial demonstrates safety and effectiveness of neoantigen DNA vaccines in triple-negative breast cancer, achieving 87.5% recurrence-free survival at 36 months.

Discover how kidney function decline in ATTR-CM patients predicts higher mortality, highlighting its role as a critical marker in disease management and care optimisation.